Megan Othus

67PUBLICATIONS
227CO-AUTHORS
Haematological tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)HaematologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (67)

|Jul 13, 2026
Randomized phase 2 trial of CPX-351 vs. CLAG-M (cladribine, cytarabine, G-CSF, and mitoxantrone) for medically unfit adults with acute myeloid leukemia or other high-grade myeloid neoplasms.

|Jun 23, 2026
Addressing Biases in Analysis of Time of Infusion: NCI/SWOG Trial S1404 Among Participants With High-Risk Resectable Melanoma Who Received Adjuvant Anti-PD-1 Therapy.

|Jun 08, 2026
Cancer Chemoimmunotherapy: Time Will Tell.

|Jun 01, 2026
[211At]Astatine-Based Conditioning with a Humanized CD45 Antibody for Autologous Hematopoietic Stem Cell Gene Therapy.

|Apr 17, 2026
A phase II basket trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART) SWOG S1609: vaginal cancer sub cohort results.

|Mar 17, 2026
Chronic myeloid leukaemia: have basophils gone the way of the Dodo bird?

Lucia Turcsanyi, Xiao-Shuai Zhang, Milos Kudelka

Pageof 12

Frequent Collaborators

26 joint publications

Roland Walter

9 joint publications

Young Kwang Chae

9 joint publications

Brenda Sandmaier

8 joint publications

Razelle Kurzrock